Form 4 for CYPH CYPHERPUNK TECHNOLOGIES INC.
Accepted 2025-04-01 00:00:00 ET · period of report 2025-03-28 · accession 0001104659-25-030804 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-01 | 2025-03-28 | CYPH | Sirard Cynthia | Chief Medical Off | M - OptEx | — | +22.5K | 27.5K | +450% | — |
| D | 2025-04-01 | 2025-03-28 | CYPH | Sirard Cynthia | Chief Medical Off | M - OptEx | $0.00 | -22.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-28 | M | A | 22,500 | — | 27,500 | D | — | — | (F3) Each of the January 2022 RSUs represented a contingent right to receive one share of the Company's Common Stock. (F2) The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023. |
| 2 | Derivative | Restricted Stock Units | 2025-03-28 | M | D | 22,500 | $0.00 | 0 | D | — · — to — | 22,500 Common Stock | (F3) Each of the January 2022 RSUs represented a contingent right to receive one share of the Company's Common Stock. (F5) The Compensation Committee of the Board of Directors took action to defer settlement of the January 2022 RSUs so that such settlement would not occur on January 31, 2025, the vesting date thereof. The January 2022 RSUs were settled on March 28, 2025 as further described on note (2) above. (F4) The January 2022 RSUs became fully vested on January 31, 2025 but settlement thereof was deferred by the Compensation Committee of the Board of Directors of the Company until March 28, 2025 pursuant to, and in accordance with, the terms of the January 2022 RSUs, which terms provide that the Compensation Committee would have the authority to defer the settlement of the January 2022 RSUs to a date later than the vesting date of the January 2022 RSUs in the event that on such vesting date the reporting person were to be subject to, among other things, any limitation or restriction under the Company's insider trading policy that would not permit the reporting person to sell on such vesting date all of the shares of the Company's Common Stock underlying the January 2022 RSUs if the January 2022 RSUs were to be settled on such vesting date. (F6) The terms of the January 2022 RSUs provide that the January 2022 RSUs would automatically terminate and be forfeited upon termination of the reporting person's employment or other service relationship with the Company if such termination of employment or service relationship were to occur at any time prior to January 31, 2022, the vesting date of the January 2022 RSUs. |